matairesinol has been researched along with hydroxymatairesinol in 4 studies
Studies (matairesinol) | Trials (matairesinol) | Recent Studies (post-2010) (matairesinol) | Studies (hydroxymatairesinol) | Trials (hydroxymatairesinol) | Recent Studies (post-2010) (hydroxymatairesinol) |
---|---|---|---|---|---|
105 | 1 | 51 | 34 | 0 | 13 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barontini, M; Belfiore, MC; Bernini, R; Crestini, C; Eklund, P; Gualandi, G; Saladino, R; Willför, S | 1 |
Ahotupa, M; Eckerman, C; Franke, AA; Kangas, L; Mäkelä, SI; Reunanen, M; Saarinen, NM; Salmi, SM; Santti, R; Wärri, A | 1 |
Eklund, P; Lehtilä, R; Lindholm, A; Mikkola, JP; Sjöholm, R; Smeds, A | 1 |
Debouche, C; During, A; Larondelle, Y; Raas, T | 1 |
4 other study(ies) available for matairesinol and hydroxymatairesinol
Article | Year |
---|---|
A novel and efficient synthesis of highly oxidized lignans by a methyltrioxorhenium/hydrogen peroxide catalytic system. Studies on their apoptogenic and antioxidant activity.
Topics: Antioxidants; Apoptosis; Catalysis; Cell Line, Tumor; Humans; Hydrogen Peroxide; Lignans; Lymphoma, B-Cell; Organometallic Compounds; Oxidation-Reduction; Structure-Activity Relationship | 2009 |
Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies).
Topics: 4-Butyrolactone; Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Female; Furans; Genitalia, Male; Lignans; Male; Mammary Neoplasms, Experimental; Phytotherapy; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Trees; Uterus | 2000 |
Synthesis of (-)-matairesinol, (-)-enterolactone, and (-)-enterodiol from the natural lignan hydroxymatairesinol.
Topics: 4-Butyrolactone; Furans; Hydrogenation; Lignans; Picea; Stereoisomerism | 2003 |
Among plant lignans, pinoresinol has the strongest antiinflammatory properties in human intestinal Caco-2 cells.
Topics: 4-Butyrolactone; Anti-Inflammatory Agents; Butylene Glycols; Caco-2 Cells; Cell Differentiation; Chemokine CCL2; Chromatography, High Pressure Liquid; Cyclooxygenase 2; Furans; Glucosides; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; Intestines; Lignans; NF-kappa B; Plant Extracts; Signal Transduction | 2012 |